Environmental risk factors for inflammatory bowel disease.

Crohn's disease (CD) and ulcerative colitis (UC) are chronic immunologically mediated diseases that often have a relapsing-remitting course in young persons. Genetic-risk polymorphisms explain less than one third of the heritability of disease. Epidemiologic and laboratory data suggest that environmental factors play a significant role in influencing the risk and natural history of disease. Smoking is the most widely and consistently described risk factor. It, however, increases the risk of CD while conferring protection against UC. The gut microbiome is a key component in the development of inflammatory bowel disease (IBD). Several external factors potentially exert an effect by influencing the composition of the gut microbiome or disrupting the intestinal barrier. These external influences include the use of antibiotics or nonsteroidal anti-inflammatory drugs and the presence of enteric infections. Data on diet have been inconsistent, but high fiber intake, particularly of soluble fiber, appears to protect against CD, whereas protein intake may increase disease risk. Vitamin D may also play an important protective role, particularly in patients with CD. Neurobehavioral factors, such as stress and depression, also influence the risk of IBD. Systematic and rigorous studies of environmental exposures in the management of IBD are needed. In particular, studies of whether environmental factors can be modified to reduce the likelihood of relapse or improve patient outcomes would be valuable.

[1]  I. Kohane,et al.  Psychiatric co‐morbidity is associated with increased risk of surgery in Crohn's disease , 2013, Alimentary pharmacology & therapeutics.

[2]  D. Quilliot,et al.  Dietary Beliefs and Behavior Among Inflammatory Bowel Disease Patients , 2013, Inflammatory bowel diseases.

[3]  A. Ananthakrishnan,et al.  Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  Robert S. Sandler,et al.  Dietary Patterns and Self-Reported Associations of Diet with Symptoms of Inflammatory Bowel Disease , 2013, Digestive Diseases and Sciences.

[5]  A. Farmer,et al.  Mood disorders in inflammatory bowel disease: Relation to diagnosis, disease activity, perceived stress, and other factors , 2012, Inflammatory bowel diseases.

[6]  J. Manson,et al.  Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. , 2012, Gastroenterology.

[7]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[8]  A. Chan,et al.  A Prospective Study of Cigarette Smoking and the Risk of Inflammatory Bowel Disease in Women , 2012, The American Journal of Gastroenterology.

[9]  J. Lewis,et al.  Food and the gut microbiota in inflammatory bowel diseases: a critical connection , 2012, Current opinion in gastroenterology.

[10]  H. Sokol,et al.  Current smoking differentially affects blood mononuclear cells from patients with crohn's disease and ulcerative colitis: Relevance to its adverse role in the disease , 2012, Inflammatory bowel diseases.

[11]  A. Ananthakrishnan,et al.  Oral contraceptives, reproductive factors and risk of inflammatory bowel disease , 2012, Gut.

[12]  A. Ananthakrishnan,et al.  863 Higher Dietary Fiber Intake is Associated With Lower Risk of Crohn's Disease but Not Ulcerative Colitis - a Prospective Study , 2012 .

[13]  J. Marshall,et al.  Management of inflammatory bowel disease with vitamin D: beyond bone health. , 2012, Journal of Crohn's & colitis.

[14]  A. Auvinen,et al.  Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study. , 2012, American journal of epidemiology.

[15]  A. Ananthakrishnan,et al.  Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis , 2012, Annals of Internal Medicine.

[16]  E. Giovannucci,et al.  Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. , 2012, Gastroenterology.

[17]  T. Greene,et al.  High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. , 2012, Kidney international.

[18]  S. Ng,et al.  Hospitalisations and surgery in Crohn's disease , 2012, Gut.

[19]  A. Ananthakrishnan,et al.  Geographical variation and incidence of inflammatory bowel disease among US women , 2012, Gut.

[20]  B. V. Pedersen,et al.  Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study , 2011, Gut.

[21]  C. Bernstein,et al.  Association Between the Use of Antibiotics and New Diagnoses of Crohn's Disease and Ulcerative Colitis , 2011, The American Journal of Gastroenterology.

[22]  C. O'Morain,et al.  Common variation in the vitamin D receptor gene and risk of inflammatory bowel disease in an Irish case–control study , 2011, European journal of gastroenterology & hepatology.

[23]  E. Riboli,et al.  Aspirin in the aetiology of Crohn’s disease and ulcerative colitis: a European prospective cohort study , 2011, Alimentary pharmacology & therapeutics.

[24]  R. Xavier,et al.  Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.

[25]  Philippe Seksik,et al.  Epidemiology and natural history of inflammatory bowel diseases. , 2011, Gastroenterology.

[26]  A. Ananthakrishnan,et al.  Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. , 2011, JPEN. Journal of parenteral and enteral nutrition.

[27]  A. Ananthakrishnan,et al.  Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease , 2011, Inflammatory bowel diseases.

[28]  M. Boutron‐Ruault,et al.  Low exposure to sunlight is a risk factor for Crohn’s disease , 2011, Alimentary pharmacology & therapeutics.

[29]  H. El‐Serag,et al.  Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature , 2011, The American Journal of Gastroenterology.

[30]  K. T. Jørgensen,et al.  Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease , 2010, Gut.

[31]  A. Tjønneland,et al.  An association between dietary arachidonic acid, measured in adipose tissue, and ulcerative colitis. , 2010, Gastroenterology.

[32]  S. Nikfar,et al.  Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis. , 2010, Clinical therapeutics.

[33]  C. Bernstein,et al.  Association Between the Use of Antibiotics in the First Year of Life and Pediatric Inflammatory Bowel Disease , 2010, The American Journal of Gastroenterology.

[34]  F. Clavel-Chapelon,et al.  Animal Protein Intake and Risk of Inflammatory Bowel Disease: The E3N Prospective Study , 2010, The American Journal of Gastroenterology.

[35]  M. Cheang,et al.  A Prospective Population-Based Study of Triggers of Symptomatic Flares in IBD , 2010, The American Journal of Gastroenterology.

[36]  J. Kelsen,et al.  Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study , 2010, Alimentary pharmacology & therapeutics.

[37]  G. Kaplan,et al.  The Inflammatory Bowel Diseases and Ambient Air Pollution: A Novel Association , 2010, The American Journal of Gastroenterology.

[38]  R. Luben,et al.  Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study , 2010, European journal of gastroenterology & hepatology.

[39]  D. Rampton,et al.  Does psychological counseling alter the natural history of inflammatory bowel disease? , 2010, Inflammatory bowel diseases.

[40]  G. Radford-Smith,et al.  Role of diet in the development of inflammatory bowel disease , 2010, Inflammatory bowel diseases.

[41]  M. Picco Increased Short- and Long-Term Risk of Inflammatory Bowel Disease After Salmonella or Campylobacter Gastroenteritis , 2010 .

[42]  D. Rampton Does Stress Influence Inflammatory Bowel Disease? The Clinical Data , 2010, Digestive Diseases.

[43]  M. Abreu,et al.  Clinical Outcomes of Patients with Ulcerative Colitis and Co-existing Clostridium difficile Infection , 2010, Digestive Diseases and Sciences.

[44]  E. Riboli,et al.  Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case–control study within a European prospective cohort study , 2009, Gut.

[45]  C. Bernstein,et al.  Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management , 2009, Inflammatory bowel diseases.

[46]  W. Khan,et al.  Reactivation of inflammatory bowel disease in a mouse model of depression. , 2009, Gastroenterology.

[47]  Dawn B. Beaulieu,et al.  S1145 Long-Term Impact of Clostridium difficile On Inflammatory Bowel Disease , 2009 .

[48]  C. Bernstein,et al.  Do NSAIDs, Antibiotics, Infections, or Stress Trigger Flares in IBD? , 2009, The American Journal of Gastroenterology.

[49]  Judy H Cho,et al.  Inflammatory bowel disease. , 2009, The New England journal of medicine.

[50]  Z. Motahari,et al.  Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease , 2008, Journal of gastroenterology and hepatology.

[51]  W. Sandborn,et al.  An Update on the Epidemiology of Inflammatory Bowel Disease in Asia , 2008, The American Journal of Gastroenterology.

[52]  J. Cosnes What is the link between the use of tobacco and IBD? , 2008, Inflammatory bowel diseases.

[53]  C. Williams Does the incidence of IBD increase when persons move from a low- to a high-risk area? , 2008, Inflammatory bowel diseases.

[54]  P. Tekkis,et al.  The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel Disease: A Meta-Analysis , 2008, The American Journal of Gastroenterology.

[55]  G E Wild,et al.  Predicting relapse in Crohn’s disease: a biopsychosocial model , 2008, Gut.

[56]  S. Kane,et al.  Hormonal Replacement Therapy After Menopause Is Protective of Disease Activity in Women With Inflammatory Bowel Disease , 2005, The American Journal of Gastroenterology.

[57]  P. Lakatos,et al.  Smoking in inflammatory bowel diseases: good, bad or ugly? , 2007, World journal of gastroenterology.

[58]  A. Ananthakrishnan,et al.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.

[59]  E. Levy,et al.  Imbalances in Dietary Consumption of Fatty Acids, Vegetables, and Fruits Are Associated With Risk for Crohn's Disease in Children , 2007, The American Journal of Gastroenterology.

[60]  Kimberly A. Reske,et al.  Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[61]  É. Lerebours,et al.  Stressful Life Events as a Risk Factor for Inflammatory Bowel Disease Onset: A Population-Based Case–Control Study , 2007, The American Journal of Gastroenterology.

[62]  M. Cantorna,et al.  Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury , 2007, BMC Immunology.

[63]  Yan Zhu,et al.  Vitamin D receptor is required to control gastrointestinal immunity in IL‐10 knockout mice , 2006, Immunology.

[64]  W. Sandborn,et al.  Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[65]  Simon Smale,et al.  Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[66]  J. Mawdsley,et al.  RECENT ADVANCES IN BASIC SCIENCE PSYCHOLOGICAL STRESS IN IBD: NEW INSIGHTS INTO PATHOGENIC AND THERAPEUTIC IMPLICATIONS , 2005 .

[67]  M. Cantorna,et al.  D-hormone and the immune system. , 2005, The Journal of rheumatology. Supplement.

[68]  Yan Zhu,et al.  Calcium and 1α,25‐dihydroxyvitamin D3 target the TNF‐α pathway to suppress experimental inflammatory bowel disease , 2005 .

[69]  Yan Zhu,et al.  Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. , 2004, The American journal of clinical nutrition.

[70]  M. Cantorna,et al.  Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease Prevalence , 2004, Experimental biology and medicine.

[71]  U. Böcker,et al.  Inflammatory Bowel Disease and Smoking: A Review of Epidemiology, Pathophysiology, and Therapeutic Implications , 2004, Inflammatory bowel diseases.

[72]  J. Cosnes Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. , 2004, Best practice & research. Clinical gastroenterology.

[73]  J. Olsen,et al.  Psychological Stress and Inflammatory Bowel Disease: A Follow-up Study in Parents Who Lost a Child in Denmark , 2004, American Journal of Gastroenterology.

[74]  E. Loftus Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.

[75]  L. Beaugerie,et al.  Gender differences in the response of colitis to smoking. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[76]  J. Welsh,et al.  A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. , 2003, Molecular endocrinology.

[77]  A. Ekbom,et al.  Appendectomy is followed by increased risk of Crohn's disease. , 2003, Gastroenterology.

[78]  A. Ekbom,et al.  Appendectomy and protection against ulcerative colitis. , 2001, The New England journal of medicine.

[79]  F. Carbonnel,et al.  Smoking cessation and the course of Crohn's disease: an intervention study. , 2001, Gastroenterology.

[80]  M. Cantorna,et al.  1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. , 2000, The Journal of nutrition.

[81]  D. Jewell,et al.  Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility , 2000, Gut.

[82]  F. Carrat,et al.  Effects of current and former cigarette smoking on the clinical course of Crohn’s disease , 1999, Alimentary pharmacology & therapeutics.

[83]  G. Corrao,et al.  Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). , 1998, International journal of epidemiology.

[84]  G. Costa,et al.  Familial and psychological risk factors of ulcerative colitis. , 1997, Italian journal of gastroenterology and hepatology.

[85]  F. Carbonnel,et al.  Effects of cigarette smoking on the long-term course of Crohn's disease. , 1996, Gastroenterology.

[86]  A. R. Tanner,et al.  Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem. , 1988, Digestion.